TBPH - Theravance Biopharma, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$27.00
DETAILS
HIGH:
$40.00
LOW:
$14.00
MEDIAN:
$27.00
CONSENSUS:
$27.00
UPSIDE:
64.94%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 954,042 | $15.5M | 0.0% | -305,899 | DECREASED |
| Greenblatt | 45,212 | $733,791 | 0.0% | +22,532 | INCREASED |
| Wood | 0 | $0 | -- | -10,500 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-20 | Sawaf Aziz | officer: SVP & CHIEF FINANCIAL OFFICER | F-InKind | 8,670 | $16.55 | $143K |
| 2026-05-20 | Grimaud Brett A. | officer: SVP, GEN COUNSEL AND SECRETARY | F-InKind | 8,829 | $16.55 | $146K |
| 2026-05-20 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | F-InKind | 5,678 | $16.55 | $94K |
| 2026-05-20 | Miller Aine | officer: SVP, DEV & HEAD OF IRE OFFICE | F-InKind | 6,827 | $16.55 | $113K |
| 2026-05-20 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 20,038 | $16.55 | $332K |
| 2026-04-01 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 75,000 | -- | -- |
| 2026-04-01 | Sawaf Aziz | officer: SVP & CHIEF FINANCIAL OFFICER | A-Award | 37,500 | -- | -- |
| 2026-04-01 | Grimaud Brett A. | officer: SVP, GEN COUNSEL AND SECRETARY | A-Award | 37,500 | -- | -- |
| 2026-04-01 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | A-Award | 18,750 | -- | -- |
| 2026-03-16 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | SELL | 7,767 | $13.92 | $108K |
| 2026-03-16 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | SELL | 15,534 | $14.00 | $217K |
| 2026-03-16 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | SELL | 7,766 | $13.92 | $108K |
| 2026-02-20 | Grimaud Brett A. | officer: SVP, GEN COUNSEL AND SECRETARY | F-InKind | 20,833 | $19.66 | $410K |
| 2026-02-20 | Sawaf Aziz | officer: SVP & CHIEF FINANCIAL OFFICER | F-InKind | 20,672 | $19.66 | $406K |
| 2026-02-20 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 74,975 | $19.66 | $1.5M |
| 2026-02-20 | Miller Aine | officer: SVP, DEV & HEAD OF IRE OFFICE | F-InKind | 16,851 | $19.66 | $331K |
| 2026-02-20 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | F-InKind | 13,929 | $19.66 | $274K |
| 2025-12-03 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | SELL | 7,766 | $18.75 | $146K |
| 2025-12-03 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | SELL | 15,534 | $18.75 | $291K |
| 2025-12-03 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | SELL | 7,767 | $18.75 | $146K |
| 2025-11-26 | BROSHY ERAN | director | M-Exempt | 14,000 | $10.15 | $142K |
| 2025-11-26 | BROSHY ERAN | director | SELL | 14,000 | $20.00 | $280K |
| 2025-11-26 | BROSHY ERAN | director | SELL | 15,501 | $20.00 | $310K |
| 2025-11-20 | Grimaud Brett A. | officer: SVP, GEN COUNSEL AND SECRETARY | F-InKind | 19,024 | $17.90 | $341K |
| 2025-11-20 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | F-InKind | 9,060 | $17.90 | $162K |